ENTITY
Keymed Biosciences

Keymed Biosciences (2162 HK)

67
Analysis
Health CareHong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
22 Sep 2024 09:43

China Healthcare Weekly (Sep.22) - CR Sanjiu's Trouble, Weight-Loss Drug Market Saturation, Keymed

​Anhui's VBP includes OTC TCM, challenging CR Sanjiu's pricing autonomy. There are concerns about weight-loss drug market saturation. CM310 missing...

Logo
379 Views
Share
15 Nov 2023 08:55

Keymed Biosciences (2162.HK) - Looking Forward to the Next Leap in Valuation

It's hard for Keymed's share price to rise significantly on its own unless there's an uptick in the entire biotech sector as a whole. Valuation...

Logo
347 Views
Share
04 Aug 2024 11:00

China Healthcare Weekly (Aug.4)- Taiji Group & China TCM, TCM Formula Granules VBP, Keymed's Trouble

​Substitution of TCM formula granules for decoction pieces is a trend despite the VBP. Keymed will face difficulties without NRDL negotiation....

Logo
308 Views
Share
30 Jun 2024 15:56

China Healthcare Weekly (Jun.30) - TCM Companies Witness Soaring Costs, Rising Stars in ADC, 1515.HK

​Investors should watch for rising TCM raw material prices. Chinese pharmaceutical companies are rising in ADC.Caution with China Resources...

Logo
373 Views
Share
bearishYSB
23 Jun 2024 15:59

China Healthcare Weekly (Jun23)-Retail Pharmacy's Dilemma, Logic to Biotech's Stock Price,YSB's Risk

​Retail pharmacies facing industry clearance due to negative policies.Biotech stock performance tied to sustainable development path. YSB faces...

Logo
351 Views
Share
x